Latest therapeutics News | Page 6

Argenica Therapeutics releases preclinical study data on its ARG007
Long-distance treatment for brain disorders
Immutep reaches enrolment target for INSIGHT-003 trial in first line NSCLC
Long-standing mystery about mRNAs resolved
Antisense Therapeutics announces outcomes in DMD combination animal study
Whiteley to lead $5.6m chronic wounds research grant
New trial uses cannabis for spinal cord injury induced chronic pain
What is Melanotan-II – the drug that the TGA urges consumers to avoid?
What is Melanotan-II – drug that TGA urges consumers to avoid?
Chimeric Therapeutics updates on CLTX CAR T clinical trial
Harnessing healing power within our cells
Newborn screening for spinal muscular atrophy improves chances of walking and quality of life: study
Scientists detail major mechanism lung cancers use to evade immune attack
Is a vaccine for melanoma on the cards?
BCM signs as anchor tenant at Dynamic One Building at TMC Helix Park
Blood test detects Alzheimer’s early
Personalised cancer care fast-tracked at Chris O’Brien Lifehouse
Over 50 years of technology transfer
Seven QIMR Berghofer research projects awarded prestigious national grants
ANU and Korean firm set sights on finding cure for blindness
Genomics key to First Nations health equality
CSL Closing of Arcturus Therapeutics Agreement
Datopotamab deruxtecan showed encouraging and durable efficacy in patients with heavily pretreated HR-positive
Comment from AGA: FDA actions on fecal microbiota therapy
Pre-clinical data for Kazia Therapeutics’ EVT801 published in cancer journal
Another impressive financial year for Manchester-born spinouts
Sonic Healthcare takes major strategic stake in Microba
Game-changing biotech company coming soon to Springfield
NPS MedicineWise Programs and Services Transition
Researchers Discover New Way to Synthesize mRNAs Enhancing Effectiveness of mRNA Drugs and Vaccines
Zelira Therapeutics announces successful enrolment in new trial Zelira Therapeutics
Tackling emerging antimalarial drug resistance in Africa
‘Gain of function’ research can create experimental viruses
Dr Larry Marshall, CSIRO Chief Executive
Long serving CSIRO Chief Executive Dr Larry Marshall to conclude third and final term June 2023
Brandon Capital Invests in neuroscience company NRG Therapeutics
BiomeBank announces world first regulatory approval for donor derived microbiome drug
Biological lasso: Enhanced drug delivery to brain
Alterity Therapeutics updates on Multiple System Atrophy study
Novel protein helps to regulate cholesterol production
Vaccination with senescent cells reduced tumor formation in mice
New AusBiotech Board fit for era
CSL Enters Licensing Agreement
Burnet welcomes grant for mRNA vaccine development
ACT-Accelerator launches six month plan as world transitions to long-term Covid control
TAG-VE statement on Omicron sublineages BQ.1 and XBB
Victorian Premier issues statement 28 October
New melanoma breakthrough by Australian company could potentially save thousands of lives